About

Faith L. Charles became an Abeona director on March 26, 2021 and chairs the Nominating and Corporate Governance Committee while serving on the Compensation Committee. She has been a corporate transactions and securities partner at the law firm Thompson Hine LLP since 2010, where she leads the Life Sciences practice and co-heads the securities practice, advising public and emerging biotech and pharmaceutical companies on financings, mergers and acquisitions, licensing and strategic collaborations. She serves on the boards of Avenue Therapeutics, Inc. (Nasdaq: ATXI) since May 2022 and CNS Pharmaceuticals, Inc. (Nasdaq: CNSP) since December 2023. She founded the Women in Bio Metro New York chapter and serves on the national board of Women in Bio. She holds a J.D. from The George Washington University Law School and a B.A. in Psychology from Barnard College, Columbia University.

Roles

Abeona Therapeutics Inc.
Director (Chair, Nominating and Corporate Governance Committee) · Current role
March 2021–present
Thompson Hine LLP
Partner, Corporate Transactions & Securities; leader of Life Sciences practice
2010 - present

External Roles

Avenue Therapeutics, Inc. (Nasdaq: ATXI)
Director
2022 - present
CNS Pharmaceuticals, Inc. (Nasdaq: CNSP)
Director (Chair of the Board)
2023 - present
Conduit Pharmaceuticals Limited (now CDT Equity Inc.)
Director
2023 - 2025
Women in Bio
National board member

Director Compensation

FY 2025
Fees earned or paid in cash
$72,500
ComponentAnnual board fee plus committee and committee-chair fees earned in 2025, paid quarterly
Stock awards
$200,000
ComponentRestricted stock award for 2025 Board service (36,101 shares granted January 31, 2025 at $5.54, ASC 718 grant-date fair value); vests one year after grant
Total
$272,500

Also at Abeona Therapeutics Inc.

Related

See how VectorShift works for your firm

Request Demo